CONMED (CNMD)
(Delayed Data from NYSE)
$70.60 USD
-1.00 (-1.40%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $70.58 -0.02 (-0.03%) 7:58 PM ET
4-Sell of 5 4
B Value B Growth A Momentum A VGM
Price, Consensus and EPS Surprise
CNMD 70.60 -1.00(-1.40%)
Will CNMD be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for CNMD based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CNMD
Conmed (CNMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Here's Why You Should Retain CONMED (CNMD) Stock for Now
CNMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Staar Surgical (STAA) Soars 7.5%: Is Further Upside Left in the Stock?
Henry Schein (HSIC) Down 4.3% Since Last Earnings Report: Can It Rebound?
Merit Medical (MMSI) Up 5% Since Last Earnings Report: Can It Continue?
Other News for CNMD
CONMED Corporation to Announce Second Quarter 2024 Financial Results on July 31, 2024
AirSeal Concerns Have Let Too Much Air Out Of Conmed's Valuation
Clearmind secures exclusive rights to potential PSTD therapies
Warning: CNMD is at high risk of performing badly
Conmed Announces Executive Transition and New Officer Compensation